FDA approves pioneering drug for ovarian cancer surgery

Ovarian cancer patient Carol Giandonato admits to being apprehensive when her oncologist told her he wanted to make her cancer cells turn fluorescent green.

Related Keywords

Runnemede ,New Jersey ,United States ,Purdue University ,Indiana ,West Lafayette ,Danielle Kirsch ,Chris Barys ,Ralphc Corley ,Chris Bayrs ,Leslie Randall ,Carol Giandonato ,National Cancer Institute ,Purdue Research Foundation Office Of Technology Commercialization ,National Institutes Of Health ,Purdue University Center ,Drug Administration ,Virginia Commonwealth University School Of Medicine ,Cancer Research ,Purdue University Presidential Scholar For Drug Discovery ,Presidential Scholar ,Drug Discovery ,Distinguished Professor ,John Underwood ,Philip Low ,Target Laboratories ,Virginia Commonwealth University School ,National Institutes ,Purdue Research Foundation Office ,World Report ,Cytalux Phase ,Clinical Study Results ,Steve Tally ,